Rydzewska-Rosolowska A - Search Results

1

Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II.

Borawski J, Zbroch E, Rydzewska-Rosolowska A, Pawlak K, Mysliwiec M. Borawski J, et al. J Nephrol. 2007 May-Jun;20(3):370-2. J Nephrol. 2007. PMID: 17557272

2

Endothelial dysfunction, atherosclerosis and thrombosis in uremia--possibilities of intervention.

Myśliwiec M, Borawski J, Naumnik B, Rydzewska-Rosołowska A. Myśliwiec M, et al. Rocz Akad Med Bialymst. 2004;49:151-6. Rocz Akad Med Bialymst. 2004. PMID: 15631332 Review.

3

Myeloperoxidase up-regulation during haemodialysis: is heparin the missing link?

Borawski J, Naumnik B, Rydzewska-Rosołowska A, Myśliwiec M. Borawski J, et al. Nephrol Dial Transplant. 2006 Apr;21(4):1128; author reply 1128-30. doi: 10.1093/ndt/gfl002. Epub 2006 Feb 7. Nephrol Dial Transplant. 2006. PMID: 16464886 No abstract available.

4

TGF-beta1 and endothelial/tissue injury with high-dose intravenous iron therapy in renal failure: evidence or perception?

Goździkiewicz J, Borawski J, Naumnik B, Rydzewska-Rosołowska A, Pawlak K, Myśliwiec M. Goździkiewicz J, et al. Clin Appl Thromb Hemost. 2006 Oct;12(4):493-4. doi: 10.1177/1076029606293837. Clin Appl Thromb Hemost. 2006. PMID: 17000896 Free article. No abstract available.

5

[SEN virus infection in maintenance hemodialysis patients].

Borawski J, Kovalchuk O, Chlebińska I, Naumnik B, Rydzewska-Rosołowska A, Chyczewski L, Myśliwiec M. Borawski J, et al. Wiad Lek. 2006;59(11-12):751-6. Wiad Lek. 2006. PMID: 17427486 Polish.

6

Staphylococcal scalded skin syndrome in the course of lupus nephritis.

Rydzewska-Rosołowska A, Brzosko S, Borawski J, Myśliwiec M. Rydzewska-Rosołowska A, et al. Nephrology (Carlton). 2008 Jun;13(3):265-6. doi: 10.1111/j.1440-1797.2007.00904.x. Nephrology (Carlton). 2008. PMID: 18315709 No abstract available.

7

High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report.

Rydzewska-Rosolowska A, Borawski J, Mysliwiec M. Rydzewska-Rosolowska A, et al. Adv Med Sci. 2009;54(2):199-202. doi: 10.2478/v10039-009-0030-7. Adv Med Sci. 2009. PMID: 19758969 Clinical Trial.

8

Intravenous and oral sulodexide versus coagulation activation markers in humans.

Borawski J, Dubowski M, Rydzewska-Rosolowska A, Mysliwiec M. Borawski J, et al. Clin Appl Thromb Hemost. 2009 Oct;15(5):596-8. doi: 10.1177/1076029609333674. Clin Appl Thromb Hemost. 2009. PMID: 19910295 Free article. No abstract available.

9

Hepatocyte growth factor/activin A/follistatin system activation during hemodialysis with different low molecular weight heparins.

Rydzewska-Rosołowska A, Borawski J, Myśliwiec M. Rydzewska-Rosołowska A, et al. Ren Fail. 2009;31(9):791-7. doi: 10.3109/08860220903180608. Ren Fail. 2009. PMID: 19925286 Free article. Clinical Trial.

10

Different effects of enoxaparin, nadroparin, and dalteparin on plasma TFPI during hemodialysis: a prospective crossover randomized study.

Naumnik B, Rydzewska-Rosołowska A, Myśliwiec M. Naumnik B, et al. Clin Appl Thromb Hemost. 2011 Oct;17(5):480-6. doi: 10.1177/1076029610376936. Epub 2010 Aug 3. Clin Appl Thromb Hemost. 2011. PMID: 20682597 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters